Join
Live feed
·
PRReleasevia Quantisnow
Eikon Therapeutics Inc. logo

Eikon Therapeutics Announces Seven Abstracts Accepted for Presentation at the 2026 European Society of Medical Oncology (ESMO) Congress

ByQuantisnow·Wall Street's wire, on your screen.
EIKN· Eikon Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EIKN (Eikon Therapeutics Inc.) and more on Quantisnow.